CorMedix Valuation
| CRMD Stock | USD 9.98 0.20 2.04% |
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. CorMedix prevailing Real Value cannot be determined due to lack of data. The current price of CorMedix is $9.98. Our model approximates the value of CorMedix from analyzing the firm fundamentals such as Return On Equity of -0.65, shares outstanding of 60.68 M, and Operating Margin of (0.29) % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that CorMedix's price fluctuation is out of control at this time. Calculation of the real value of CorMedix is based on 3 months time horizon. Increasing CorMedix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CorMedix stock is determined by what a typical buyer is willing to pay for full or partial control of CorMedix. Since CorMedix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CorMedix Stock. However, CorMedix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.98 | Real 0.0 | Hype 0.0 | Naive 10.33 |
The real value of CorMedix Stock, also known as its intrinsic value, is the underlying worth of CorMedix Company, which is reflected in its stock price. It is based on CorMedix's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CorMedix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CorMedix helps investors to forecast how CorMedix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CorMedix more accurately as focusing exclusively on CorMedix's fundamentals will not take into account other important factors: CorMedix Total Value Analysis
CorMedix is currently expected to have valuation of 547.95 M with market capitalization of 605.56 M, debt of 667.63 K, and cash on hands of 64.62 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CorMedix fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
547.95 M | 605.56 M | 667.63 K | 64.62 M |
CorMedix Asset Utilization
One of the ways to look at asset utilization of CorMedix is to check how much profit was generated for every dollar of assets it reports. CorMedix shows a negative utilization of assets of -0.38 percent, losing $0.003769 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of CorMedix shows how discouraging it operates for each dollar spent on its assets.CorMedix Ownership Allocation
CorMedix holds a total of 60.68 Million outstanding shares. 30% of CorMedix outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CorMedix Profitability Analysis
Net Loss for the year was (46.34 M) with profit before overhead, payroll, taxes, and interest of 61.67 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CorMedix's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CorMedix and how it compares across the competition.
About CorMedix Valuation
The stock valuation mechanism determines CorMedix's current worth on a weekly basis. Our valuation model uses a comparative analysis of CorMedix. We calculate exposure to CorMedix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CorMedix's related companies.CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Cormedix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.
CorMedix Growth Indicators
Investing in growth stocks can be very risky. If the company such as CorMedix does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 50.9 M | |
| Forward Price Earnings | 37.594 |
Complementary Tools for CorMedix Stock analysis
When running CorMedix's price analysis, check to measure CorMedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CorMedix is operating at the current time. Most of CorMedix's value examination focuses on studying past and present price action to predict the probability of CorMedix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CorMedix's price. Additionally, you may evaluate how the addition of CorMedix to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |